Hyperuricemia and Gout in Solid-Organ Transplant: Update in Pharmacological Management
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hyperuricemia and Gout in Solid-Organ Transplant: Update in Pharmacological Management
Authors
Keywords
-
Journal
Progress in Transplantation
Volume 25, Issue 3, Pages 263-270
Publisher
SAGE Publications
Online
2015-08-27
DOI
10.7182/pit2015322
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial
- (2013) Essack Mitha et al. RHEUMATOLOGY
- Treatment of Acute Gouty Arthritis in Complex Hospitalized Patients With Anakinra
- (2013) Pradipta Ghosh et al. ARTHRITIS CARE & RESEARCH
- Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
- (2012) Naomi Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout
- (2011) Robert T. Keenan et al. AMERICAN JOURNAL OF MEDICINE
- Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors
- (2011) Robert A. Terkeltaub et al. ARTHRITIS AND RHEUMATISM
- Pegloticase
- (2011) Katherine A. Lyseng-Williamson DRUGS
- Contemporary epidemiology of gout in the UK general population
- (2011) Lucía Cea Soriano et al. ARTHRITIS RESEARCH & THERAPY
- A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)
- (2010) A. Durrbach et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities
- (2010) A. Ioan-Facsinay et al. ANNALS OF THE RHEUMATIC DISEASES
- Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma
- (2010) R. T. Domsic et al. ANNALS OF THE RHEUMATIC DISEASES
- High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study
- (2010) Robert A. Terkeltaub et al. ARTHRITIS AND RHEUMATISM
- Effectiveness of a single 3-mg rasburicase dose for the management of hyperuricemia in patients with hematological malignancies
- (2010) S M Trifilio et al. BONE MARROW TRANSPLANTATION
- Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients: A Randomized Phase II Study
- (2010) L. Rostaing et al. Clinical Journal of the American Society of Nephrology
- Interactions of urate transporter URAT1 in human kidney with uricosuric drugs
- (2010) HO JUNG SHIN et al. NEPHROLOGY
- The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
- (2010) Michael A Becker et al. ARTHRITIS RESEARCH & THERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started